The PE Ratio as of December 2024 (TTM) for ADC Therapeutics SA (ADCT) is -0.83

According to ADC Therapeutics SA’s latest financial reports and current stock price. The company's current PE Ratio is -0.83. This represents a change of -50.11% compared to the average of -1.66 of the last 4 quarters.

ADC Therapeutics SA (ADCT) Historical PE Ratio (quarterly & annually)

How has ADCT PE Ratio performed in the past?

The mean historical PE Ratio of ADC Therapeutics SA over the last ten years is -8.39. The current -0.83 PE Ratio has changed 888.99% with respect to the historical average. Over the past ten years (40 quarters), ADCT's PE Ratio was at its highest in in the September 2023 quarter at -0.39. The PE Ratio was at its lowest in in the September 2020 quarter at -28.77.

ADC Therapeutics SA (ADCT) PE Ratio by Quarter and Year

Discovering the peaks and valleys of ADC Therapeutics SA PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

ADC Therapeutics SA (ADCT) Average PE Ratio

How has ADCT PE Ratio performed in the past?

The current PE Ratio of ADC Therapeutics SA (ADCT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

ADC Therapeutics SA (ADCT) PE Ratio vs. Peers

How is ADCT’s PE Ratio compared to its peers?

ADC Therapeutics SA’s PE Ratio is less than Passage Bio, Inc. (-0.58), greater than Black Diamond Therapeutics, Inc. (-1.69), less than TCR2 Therapeutics Inc. (-0.38), greater than Harpoon Therapeutics, Inc. (-122.60), greater than Alector, Inc. (-1.17), less than Century Therapeutics, Inc. (-0.67), less than Homology Medicines, Inc. (-0.01), less than Generation Bio Co. (-0.50), greater than Stoke Therapeutics, Inc. (-6.20), greater than Ultragenyx Pharmaceutical Inc. (-7.49), greater than Crinetics Pharmaceuticals, Inc. (-15.55), greater than Arvinas, Inc. (-4.21), greater than Revolution Medicines, Inc. (-12.93), greater than Kura Oncology, Inc. (-3.93), greater than Akero Therapeutics, Inc. (-8.30), greater than Avidity Biosciences, Inc. (-13.92), less than Protagonist Therapeutics, Inc. (14.68), greater than Design Therapeutics, Inc. (-7.36), less than ALX Oncology Holdings Inc. (-0.65), greater than Aadi Bioscience, Inc. (-1.25), less than AlloVir, Inc. (-0.52),

Build a custom stock screener for ADC Therapeutics SA (ADCT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ADC Therapeutics SA using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ADC Therapeutics SA (ADCT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ADC Therapeutics SA or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.